Stephen A Sherwin's Net Worth
$26 Million
Who is Stephen A Sherwin?
Stephen A Sherwin has an estimated net worth of $26 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., NEUROCRINE BIOSCIENCES INC, BIOSANTE PHARMACEUTICALS INC, Verastem, Inc., ADURO BIOTECH, INC., Neon Therapeutics, Inc., BioPlus Acquisition Corp., RIGEL PHARMACEUTICALS INC, VICAL INC, Epiphany Technology Acquisition Corp., and CELL GENESYS INC.
SEC CIK
Stephen A Sherwin's CIK is 0001079462
Past Insider Trading and Trends
2004 was Stephen A Sherwin's most active year for acquiring shares with 13 total transactions. Stephen A Sherwin's most active month to acquire stocks was the month of April. 2009 was Stephen A Sherwin's most active year for disposing of shares, totalling 16 transactions. Stephen A Sherwin's most active month to dispose stocks was the month of September. 2004 saw Stephen A Sherwin paying a total of $1,682,156.34 for 131,690 shares, this is the most they've acquired in one year. In 2015 Stephen A Sherwin cashed out on 29,051 shares for a total of $2,529,415.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN INC. (BIIB) Snapshot price: $241.645
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.15% | 1.34K |
—
|
—
| 20.08K |
Jun 21
| |||
Form 4
| +5.40% | 960 |
—
|
—
| 18.74K |
Jun 26
| |||
Form 4
| +8.01% | 1.37K |
—
|
—
| 18.47K |
Jun 15
| |||
Form 4
| +4.75% | 775 |
—
|
—
| 17.1K |
Jul 1
| |||
Form 4
| +5.76% | 890 |
—
|
—
| 16.33K |
Jun 3
| |||
Form 4
| +175.97% | 9.84K |
$176.84 | -$801.68 | 15.44K |
Scheduled
|
Mar 11
| ||
Form 4
| +22.37% | 1.16K |
—
|
—
| 6.32K |
Jun 19
| |||
Form 4
| -14.13% | -850.00 |
—
|
—
| 5.16K |
Oct 31
| |||
Form 4
| +17.14% | 880 |
—
|
—
| 6.01K |
Jun 12
| |||
Form 4
| -14.20% | -850.00 |
—
|
—
| 5.13K |
Nov 29
| |||
Form 4
| +21.40% | 1.05K |
—
|
—
| 5.98K |
Jun 7
| |||
Form 4
| -16.93% | -1.00K |
—
|
—
| 4.91K |
Nov 8
| |||
Form 4
| +21.88% | 1.06K |
—
|
—
| 5.91K |
Jun 8
| |||
Form 4
| +16.75% | 695 |
—
|
—
| 4.84K |
Jun 10
| |||
Form 4
| -6.21% | -275.00 |
$234.75 | -$2,099,100.00 | 4.15K |
Scheduled
|
Mar 6 - Mar 10
| ||
Form 4
| -8.39% | -405.00 |
—
|
—
| 4.42K |
Dec 1
| |||
Form 4
| +21.97% | 870 |
—
|
—
| 4.83K |
Jun 12
| |||
Form 4
|
—
|
0
|
$169.55 | -$1,207,048.50 | 3.96K |
Scheduled
|
Jan 2
| ||
Form 4
| +49.15% | 1.3K |
—
|
—
| 3.96K |
Jun 12
| |||
Form 4
|
—
|
0
|
$146.54 | -$2,224,413.62 | 2.65K |
Scheduled
|
Jun 3
| ||
Form 4
| -36.10% | -1.50K |
$176.88 | -$265,320.00 | 2.65K |
Scheduled
|
Mar 22
| ||
Form 4
| -32.49% | -2.00K |
$145.90 | -$291,800.00 | 4.16K |
Scheduled
|
Sep 4
| ||
Form 4
| +48.85% | 2.02K |
—
|
—
| 6.16K |
Jun 8
| |||
Form 4
| -37.68% | -2.50K |
$126.45 | -$316,125.00 | 4.13K |
Scheduled
|
Jun 4
| ||
Form 4
| -27.37% | -2.50K |
$110.88 | -$277,200.00 | 6.63K |
Scheduled
|
Dec 19
| ||
Form 4
| +46.51% | 2.9K |
—
|
—
| 9.13K |
Jun 1
| |||
Form 4
| +1,147.00% | 5.74K |
—
|
—
| 6.24K |
Jun 9
| |||
Form 4
|
∞
| 500 |
—
|
—
| 500 |
Mar 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $137.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$89.07 | -$3,551,214.50 | 26.5K |
Scheduled
|
May 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +18.83% | 4.2K |
—
|
—
| 26.5K |
May 17
| |||
Form 4
| -10.98% | -2.75K |
—
|
—
| 22.3K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
$65.86 | -$3,180,378.00 | 25.05K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
$40.55 | -$1,016,478.00 | 25.05K |
Scheduled
|
Jan 24
| ||
Form 4
| -7.39% | -2.00K |
—
|
—
| 25.05K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -9.40% | -2.81K |
—
|
—
| 27.05K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -37.20% | -17.69K |
$99.39 | -$1,757,965.76 | 29.86K |
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| -17.38% | -10.00K |
$98.44 | -$984,420.00 | 47.55K |
Scheduled
|
Jun 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
| +31.15% | 13.67K |
$43.25 | $15.36 | 57.55K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +46.03% | 13.83K |
$23.50 | $31.60 | 43.88K |
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +87.45% | 14.02K |
$24.97 | $33.48 | 30.05K |
Apr 14
| |||
Form 4
| +471.28% | 13.22K |
$22.48 | $4.80 | 16.03K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +83.28% | 1.27K |
$13.11 | $6.00 | 2.81K |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
∞
| 1.53K |
$11.38 | $1.65 | 1.53K |
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
$26.52 | -$112,422.00 |
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOSANTE PHARMACEUTICALS INC (ANIP) Snapshot price: $56.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
∞
| 86.76K |
—
|
—
| 86.76K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $13.478
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
∞
| 2.5K |
$8.56 | $21,395.00 | 2.5K |
Dec 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADURO BIOTECH, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||